0001901829-22-000001.txt : 20220105 0001901829-22-000001.hdr.sgml : 20220105 20220105112131 ACCESSION NUMBER: 0001901829-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220105 DATE AS OF CHANGE: 20220105 EFFECTIVENESS DATE: 20220105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cerberus Therapeutics, Inc. CENTRAL INDEX KEY: 0001901829 IRS NUMBER: 850709467 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-427909 FILM NUMBER: 22509950 BUSINESS ADDRESS: STREET 1: 6 W. HILL PL. CITY: BOSTON STATE: MA ZIP: 02114 BUSINESS PHONE: 617-416-6228 MAIL ADDRESS: STREET 1: 6 W. HILL PL. CITY: BOSTON STATE: MA ZIP: 02114 D 1 primary_doc.xml X0708 D LIVE 0001901829 Cerberus Therapeutics, Inc. 6 W. HILL PL. BOSTON MA MASSACHUSETTS 02114 617-416-6228 DELAWARE None None Corporation true 2020 Harvey Lodish 6 W. HILL PL. Boston MA MASSACHUSETTS 02114 Director Novalia Pishesha 6 W. HILL PL. Boston MA MASSACHUSETTS 02114 Executive Officer Director Xiaohong Sang 6 W. HILL PL. Boston MA MASSACHUSETTS 02114 Executive Officer Xiaowei Jin 6 W. HILL PL. Boston MA MASSACHUSETTS 02114 Director Biotechnology Decline to Disclose 06b false 2021-12-22 false true false 0 5000000 4000000 1000000 false 1 0 0 0 false Cerberus Therapeutics, Inc. Novalia Pishesha Novalia Pishesha President 2022-01-05